Replacement techniques to reduce animal experiments in drug and nanoparticle development
Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans. Numerous drugs and nanoparticles have been developed through animal tests, and development in medical nanotechnology is progressing rapidly. Howe...
Saved in:
Published in | Journal of pharmaceutical investigation Vol. 50; no. 3; pp. 327 - 335 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Singapore
Springer Singapore
01.05.2020
한국약제학회 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans. Numerous drugs and nanoparticles have been developed through animal tests, and development in medical nanotechnology is progressing rapidly. However, a good experiment requires many animals. The primary measures to reduce animal experiments include reducing the number of animals used in each experiment and replacing laboratory animals with inanimate, cellular, or inferior animals to reduce sacrifices.
Area covered
Developing nanoparticles using simulations rather than experiments may be another alternative. Instead of animals, human cells or animal-derived organs, tissues, or cells could be used in experiments. These methods allow rapid toxicity and efficacy testing at low cost. However, the disadvantage of these methods is that they cannot accurately replicate the complex interrelationships between human organs, biological reactions to specific routes of administration, or toxicity of substances resulting from metabolic processes. To overcome these shortcomings of in vitro tests, new technologies such as organoids and organ-on-chips are progressing. These can be used to quickly examine the efficacy of newly developed drugs and nanoparticles and can be useful in developing patient-tailored agents.
Expert opinion
These technologies offer some promise but it is still difficult to entirely replace animal experiments. However, the scope of methods to replace experimental animals is widening, suggesting the potential to refine, reduce, and ultimately replace animal testing. |
---|---|
AbstractList | Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans. Numerous drugs and nanoparticles have been developed through animal tests, and development in medical nanotechnology is progressing rapidly. However, a good experiment requires many animals. The primary measures to reduce animal experiments include reducing the number of animals used in each experiment and replacing laboratory animals with inanimate, cellular, or inferior animals to reduce sacrifices.
Area covered Developing nanoparticles using simulations rather than experiments may be another alternative. Instead of animals, human cells or animal-derived organs, tissues, or cells could be used in experiments. These methods allow rapid toxicity and efficacy testing at low cost. However, the disadvantage of these methods is that they cannot accurately replicate the complex interrelationships between human organs, biological reactions to specific routes of administration, or toxicity of substances resulting from metabolic processes. To overcome these shortcomings of in vitro tests, new technologies such as organoids and organ-on-chips are progressing. These can be used to quickly examine the efficacy of newly developed drugs and nanoparticles and can be useful in developing patient-tailored agents.
Expert opinion These technologies offer some promise but it is still difficult to entirely replace animal experiments. However, the scope of methods to replace experimental animals is widening, suggesting the potential to refine, reduce, and ultimately replace animal testing. KCI Citation Count: 4 Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans. Numerous drugs and nanoparticles have been developed through animal tests, and development in medical nanotechnology is progressing rapidly. However, a good experiment requires many animals. The primary measures to reduce animal experiments include reducing the number of animals used in each experiment and replacing laboratory animals with inanimate, cellular, or inferior animals to reduce sacrifices. Area covered Developing nanoparticles using simulations rather than experiments may be another alternative. Instead of animals, human cells or animal-derived organs, tissues, or cells could be used in experiments. These methods allow rapid toxicity and efficacy testing at low cost. However, the disadvantage of these methods is that they cannot accurately replicate the complex interrelationships between human organs, biological reactions to specific routes of administration, or toxicity of substances resulting from metabolic processes. To overcome these shortcomings of in vitro tests, new technologies such as organoids and organ-on-chips are progressing. These can be used to quickly examine the efficacy of newly developed drugs and nanoparticles and can be useful in developing patient-tailored agents. Expert opinion These technologies offer some promise but it is still difficult to entirely replace animal experiments. However, the scope of methods to replace experimental animals is widening, suggesting the potential to refine, reduce, and ultimately replace animal testing. |
Author | Jin, Ik Sup Yoon, Moon Sup Hong, Jin Tae Chung, Youn Bok Kim, Jin-Seok Park, Chun-Woong Shin, Dae Hwan |
Author_xml | – sequence: 1 givenname: Ik Sup surname: Jin fullname: Jin, Ik Sup organization: College of Pharmacy, Chungbuk National University – sequence: 2 givenname: Moon Sup surname: Yoon fullname: Yoon, Moon Sup organization: College of Pharmacy, Chungbuk National University – sequence: 3 givenname: Chun-Woong surname: Park fullname: Park, Chun-Woong organization: College of Pharmacy, Chungbuk National University – sequence: 4 givenname: Jin Tae surname: Hong fullname: Hong, Jin Tae organization: College of Pharmacy, Chungbuk National University – sequence: 5 givenname: Youn Bok surname: Chung fullname: Chung, Youn Bok organization: College of Pharmacy, Chungbuk National University – sequence: 6 givenname: Jin-Seok surname: Kim fullname: Kim, Jin-Seok organization: Drug Information Research Institute, College of Pharmacy, Sookmyung Women’s University – sequence: 7 givenname: Dae Hwan surname: Shin fullname: Shin, Dae Hwan email: dshin@chungbuk.ac.kr organization: College of Pharmacy, Chungbuk National University |
BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002587441$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kEtLAzEUhYNUsNb-AVfZuhjNYzKdLEvxUSgIpYK7kCZ36rTTZExmRP-9ace1q3PhfOfCOddo5LwDhG4puaeEzB5iTggRGWEkIyQvZ1l5gcaMSJ4VjOajv1sIwa7QNMY9OeEFLUs5Ru9raBtt4Aiuwx2YD1d_9hBx53EA2xvA2tVH3WD4biHUJyzi2mEb-l2yLHba-VaHrjYNYAtf0Pj2RN2gy0o3EaZ_OkFvT4-bxUu2en1eLuarzHAmuowzYw1jxVYDLywvk-SysBKY5oxbY2UhCPBkV7yY0aIShBoicl1JtqVbzifobvjrQqUOplZe12fdeXUIar7eLJVkkopcJpYNrAk-xgCValMlHX4UJeo0pRqmVGlKdZ5SlSnEh1BMsNtBUHvfB5c6_Zf6BT-YeX4 |
CitedBy_id | crossref_primary_10_3390_pharmaceutics13111928 crossref_primary_10_1016_j_bios_2023_115100 crossref_primary_10_3390_pharmaceutics12060555 crossref_primary_10_4315_JFP_21_184 crossref_primary_10_1093_gigascience_giad049 crossref_primary_10_3390_pharmaceutics14071451 crossref_primary_10_1002_advs_202101437 crossref_primary_10_1371_journal_pone_0283825 |
Cites_doi | 10.1517/17425255.2.6.875 10.1080/07853890310016333 10.1007/s40005-019-00434-2 10.1021/acs.jpcc.8b07616 10.1021/ac001132d 10.1016/j.addr.2006.09.011 10.1002/ppul.23773 10.2147/COPD.S62053 10.1016/j.ijpharm.2009.04.030 10.1016/j.cell.2014.08.016 10.1016/j.ijpharm.2017.01.006 10.1039/C7NR07898F 10.1016/j.jconrel.2014.08.027 10.1517/17425255.2012.648613 10.1063/1.2345914 10.1039/b504403k 10.1016/j.drudis.2011.10.023 10.2174/138161205774414510 10.1016/j.cell.2007.08.006 10.1038/s41598-017-02365-0 10.1080/10590501.2016.1166879 10.1016/j.nano.2009.06.001 10.1016/j.ces.2007.05.006 10.1063/1.3486610 10.1038/nrd4539 10.1038/ncomms14250 10.1016/j.stem.2013.11.002 10.1016/j.cbpa.2010.08.016 10.1021/ci5000467 10.1053/j.gastro.2011.07.050 10.1039/b901377f 10.1007/s11948-015-9659-8 10.1038/nnano.2012.168 10.1103/RevModPhys.77.977 10.1039/B711887B 10.1002/jbm.a.36305 10.1038/ncb3632 10.1126/science.1217815 10.1073/pnas.0915130107 10.1021/acs.chemrestox.5b00465 10.1517/17425247.2011.559457 10.1038/nbt.2989 10.1039/C0CS00003E 10.1021/acs.chemrestox.7b00083 10.1158/0008-5472.CAN-14-0663 10.1016/S0022-2836(65)80093-6 10.1016/j.biomaterials.2014.04.060 10.1038/nrm1858 10.1016/j.cell.2016.05.082 10.1038/nrd1032 10.1038/s41419-019-1453-0 10.1016/j.jconrel.2013.07.026 10.1038/nm.3973 10.1146/annurev-cellbio-101512-122340 10.1098/rsif.2017.0137 10.1039/C6IB00162A 10.1021/ac901560w 10.1039/b900912d 10.1146/annurev-bioeng-060418-052305 10.1038/s41467-019-11867-6 10.1021/acs.jcim.7b00244 10.1038/nrc1456 |
ContentType | Journal Article |
Copyright | The Korean Society of Pharmaceutical Sciences and Technology 2020 |
Copyright_xml | – notice: The Korean Society of Pharmaceutical Sciences and Technology 2020 |
DBID | AAYXX CITATION ACYCR |
DOI | 10.1007/s40005-020-00487-8 |
DatabaseName | CrossRef Korean Citation Index |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2093-6214 |
EndPage | 335 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9291549 10_1007_s40005_020_00487_8 |
GrantInformation_xml | – fundername: National Research Foundation of Korea grantid: NRF-2019R1C1C1009996 – fundername: National Research Foundation (KR) grantid: MRC2017R1A5A2015541 |
GroupedDBID | -EM .UV 06D 0R~ 0VY 203 29~ 30V 4.4 406 408 96X 9ZL AAAVM AAFGU AAHNG AAIAL AAJKR AANXM AANZL AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO AAZMS ABDZT ABECU ABFGW ABFTV ABJNI ABJOX ABKAS ABKCH ABMQK ABPLI ABQBU ABTEG ABTHY ABTKH ABTMW ABXPI ACBMV ACBRV ACBYP ACCUX ACGFS ACHSB ACIGE ACIPQ ACKNC ACMLO ACOKC ACTTH ACVWB ACWMK ADHHG ADHIR ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFTE AEGNC AEJHL AEJRE AEOHA AEPYU AESKC AESTI AETCA AEVLU AEVTX AEXYK AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGMZJ AGQMX AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKLTO AKMHD AKQUC ALFXC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR ANMIH AUKKA AXYYD BGNMA CSCUP DNIVK DPUIP EBLON EBS EIOEI EJD ESBYG FERAY FIGPU FINBP FNLPD FRP FRRFC FSGXE FYJPI GGCAI GGRSB GJIRD GQ6 GQ7 HMJXF HRMNR HZ~ I0C IKXTQ IWAJR IXD J-C JBSCW JDI JZLTJ KOV LLZTM M4Y NPVJJ NQJWS NU0 O9- O9J PT4 RLLFE RSV S3A SBL SHX SISQX SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE TSG U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW Z7U Z87 ZMTXR ZOVNA ~A9 AACDK AAJBT AASML AAYXX ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU CITATION ROL SJYHP ACYCR |
ID | FETCH-LOGICAL-c325t-32cdc226bae36d38ae3496d9e2a323dcd9650e3baef36716f501c054af92b1b33 |
IEDL.DBID | AGYKE |
ISSN | 2093-5552 |
IngestDate | Tue Nov 21 21:39:31 EST 2023 Thu Sep 12 18:26:33 EDT 2024 Sat Dec 16 12:10:47 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Organoid Animal ethics Drug development Nanoparticle Animal experiment replacement Biochip |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c325t-32cdc226bae36d38ae3496d9e2a323dcd9650e3baef36716f501c054af92b1b33 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9291549 crossref_primary_10_1007_s40005_020_00487_8 springer_journals_10_1007_s40005_020_00487_8 |
PublicationCentury | 2000 |
PublicationDate | 2020-05-01 |
PublicationDateYYYYMMDD | 2020-05-01 |
PublicationDate_xml | – month: 05 year: 2020 text: 2020-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Singapore |
PublicationPlace_xml | – name: Singapore |
PublicationTitle | Journal of pharmaceutical investigation |
PublicationTitleAbbrev | J. Pharm. Investig |
PublicationYear | 2020 |
Publisher | Springer Singapore 한국약제학회 |
Publisher_xml | – name: Springer Singapore – name: 한국약제학회 |
References | Kim, Lee, Pyo, Tran, Park (CR31) 2020; 50 Sekine, Yanagibori, Suzuki, Sugiyama, Yamaji, Ishibashi, Fujisawa (CR50) 2014; 9 Kwak, Ozcelikkale, Shin, Park, Han (CR33) 2014; 194 Astashkina, Jones, Thiagarajan, Kurtzeborn, Ghandehari, Brooks, Grainger (CR2) 2014; 35 Wei, Hao, Yuan, Li, Juan, Sha, Fang (CR59) 2009; 376 Van De Waterbeemd, Gifford (CR57) 2003; 2 Yang, Li, Wu, Li, Liu, Tang (CR63) 2017; 30 Valencia, Farokhzad, Karnik, Langer (CR56) 2012; 7 Walsh, Cook, Sanders, Aurisicchio, Ciliberto, Arteaga, Skala (CR58) 2014; 74 Batrakova, Gendelman, Kabanov (CR4) 2011; 8 Moroy, Martiny, Vayer, Villoutreix, Miteva (CR41) 2012; 17 Li, Chen, Cheng, Wu, Bian, Xu, Li, Liu, Shen, Tang (CR34) 2014; 54 Mulliner, Schmidt, Stolte, Spirkl, Czich, Amberg (CR43) 2016; 29 Gupta, Rai (CR23) 2018; 10 Sato, Stange, Ferrante, Vries, Van Es, Van Den Brink, Van Houdt, Pronk, Van Gorp, Siersema, Clevers (CR47) 2011; 141 Esch, Bahinski, Huh (CR15) 2015; 14 Heldin, Rubin, Pietras, Stman (CR24) 2004; 4 Cruz-Acuna, Quiros, Farkas, Dedhia, Huang, Siuda, Garcia-Hernandez, Miller, Spence, Nusrat, Garcia (CR9) 2017; 19 Davoudi, Peroutka-Bigus, Bellaire, Wannemuehler, Barrett, Narasimhan, Wang (CR12) 2018; 106 Korin, Kanapathipillai, Matthews, Crescente, Brill, Mammoto, Ghosh, Jurek, Bencherif, Bhatta, Coskun, Feldman, Wagner, Ingber (CR32) 2012; 337 CR42 Golbamaki, Benfenati, Golbamaki, Manganaro, Merdivan, Roncaglioni, Gini (CR19) 2016; 34 Mahto, Yoon, Rhee (CR37) 2010; 4 Curzer, Perry, Wallace, Perry (CR10) 2016; 22 Keenan, Hsu, Folch (CR29) 2006; 89 Ehrlich, Duche, Ouedraogo, Nahmias (CR14) 2019; 21 Flaim, Chien, Bhatia (CR17) 2005; 2 Yamada, Cukierman (CR62) 2007; 130 Abu Lila, Kiwada, Ishida (CR1) 2013; 172 Przybylak, Cronin (CR46) 2012; 8 Zhang, Ai, Chen, Yin, Hu, Zhu, Zhao, Zhao, Liu (CR66) 2017; 7 Blais, Rawls, Dougherty, Li, Kolling, Ye, Wallqvist, Papin (CR6) 2017; 8 Wlodkowic, Cooper (CR60) 2010; 14 Ingber (CR27) 2003; 35 Lunnoo, Assawakhajornsak, Puangmali (CR36) 2019; 123 Bhatia, Ingber (CR5) 2014; 32 Li, Guo, Yu, Xu, Xu, Qin (CR35) 2016; 8 Chou, Ming, Chan (CR7) 2011; 40 Farokhzad, Langer (CR16) 2006; 58 Ploss, Khetani, Jones, Syder, Trehan, Gaysinskaya, Mu, Ritola, Rice, Bhatia (CR45) 2010; 107 Xu, Pei, Lai (CR61) 2017; 57 Huang, Holtzinger, Jagan, Begora, Lohse, Ngai, Nostro, Wang, Muthuswamy, Crawford, Arrowsmith, Kalloger, Renouf, Connor, Cleary, Schaeffer, Roehrl, Tsao, Gallinger, Keller, Muthuswamy (CR26) 2015; 21 Griffith, Swartz (CR21) 2006; 7 Clevers (CR8) 2016; 165 Schuster, Laggner, Langer (CR48) 2005; 11 Tsai, Trubelja, Shen, Bao (CR55) 2017; 14 Squires, Quake (CR52) 2005; 77 Yu, Meyvantsson, Shkel, Beebe (CR65) 2005; 5 Keenan, Folch (CR28) 2008; 8 Davidson, Harvie (CR11) 2007; 62 Murday, Siegel, Stein, Wright (CR44) 2009; 5 Dertinger, Chiu, Jeon, Whitesides (CR13) 2001; 73 Mannino, Homa, Akinbami, Ford, Redd (CR39) 2002; 51 Schwank, Koo, Sasselli, Dekkers, Heo, Demircan, Sasaki, Boymans, Cuppen, Van der Ent, Nieuwenhuis, Beekman, Clevers (CR49) 2013; 13 Sung, Shuler (CR53) 2009; 9 Gao, Vela, Sboner, Iaquinta, Karthaus, Gopalan, Dowling, Wanjala, Undvall, Arora, Wongvipat, Kossai, Ramazanoglu, Barboza, Di, Cao, Zhang, Sirota, Ran, Macdonald, Beltran, Mosquera, Touijer, Scardino, Laudone, Curtis, Rathkopf, Morris, Danila, Slovin, Solomon, Eastham, Chi, Carver, Rubin, Scher, Clevers, Sawyers, Chen (CR18) 2014; 159 CR25 Martignoni, Groothuis, De Kanter (CR40) 2006; 2 Shin, Kwon (CR51) 2017; 518 Guimbellot, Sharma, Rowe (CR22) 2017; 52 Mammoto, Mammoto, Ingber (CR38) 2013; 29 Kim, Mun, Sung, Cho, Jeon, Chun, Jung, Shin, Jeong, Kim, Choi, Jeong, Taylor, Jain, Meyerson, Jang (CR30) 2019; 10 Grassi, Alfonsi, Francescangeli, Signore, De Angelis, Addario, Costantini, Flex, Ciolfi, Pizzi, Bruselles, Pallocca, Simone, Haoui, Falchi, Milella, Sentinelli, Di Matteo, Stellacci, Gallucci, Muto, Tartaglia, De Maria, Bonci (CR20) 2019; 10 Young, Watson, Srigunapalan, Wheeler, Simmons (CR64) 2010; 82 Toh, Lim, Tai, Xiao, Van Noort, Yu (CR54) 2009; 9 Bangham, Standish, Watkins (CR3) 1965; 13 J Guimbellot (487_CR22) 2017; 52 DM Mannino (487_CR39) 2002; 51 EW Esch (487_CR15) 2015; 14 D-H Kim (487_CR31) 2020; 50 Z Wei (487_CR59) 2009; 376 R Gupta (487_CR23) 2018; 10 A Ploss (487_CR45) 2010; 107 Y Xu (487_CR61) 2017; 57 J Murday (487_CR44) 2009; 5 G Schwank (487_CR49) 2013; 13 HJ Curzer (487_CR10) 2016; 22 OC Farokhzad (487_CR16) 2006; 58 M Kim (487_CR30) 2019; 10 PM Valencia (487_CR56) 2012; 7 LYT Chou (487_CR7) 2011; 40 L Grassi (487_CR20) 2019; 10 487_CR25 T Sato (487_CR47) 2011; 141 AD Bangham (487_CR3) 1965; 13 AJ Walsh (487_CR58) 2014; 74 D Gao (487_CR18) 2014; 159 H Yang (487_CR63) 2017; 30 TM Keenan (487_CR28) 2008; 8 H Yu (487_CR65) 2005; 5 AS Abu Lila (487_CR1) 2013; 172 Y Sekine (487_CR50) 2014; 9 SK Mahto (487_CR37) 2010; 4 TM Keenan (487_CR29) 2006; 89 H Van De Waterbeemd (487_CR57) 2003; 2 SKW Dertinger (487_CR13) 2001; 73 A Golbamaki (487_CR19) 2016; 34 JH Sung (487_CR53) 2009; 9 Y-C Toh (487_CR54) 2009; 9 M Martignoni (487_CR40) 2006; 2 R Cruz-Acuna (487_CR9) 2017; 19 KR Przybylak (487_CR46) 2012; 8 EV Batrakova (487_CR4) 2011; 8 G Moroy (487_CR41) 2012; 17 LG Griffith (487_CR21) 2006; 7 MR Davidson (487_CR11) 2007; 62 Z Davoudi (487_CR12) 2018; 106 T Lunnoo (487_CR36) 2019; 123 TM Squires (487_CR52) 2005; 77 D Ingber (487_CR27) 2003; 35 X Li (487_CR34) 2014; 54 KM Yamada (487_CR62) 2007; 130 D Mulliner (487_CR43) 2016; 29 C-H Heldin (487_CR24) 2004; 4 A Ehrlich (487_CR14) 2019; 21 EWK Young (487_CR64) 2010; 82 CJ Flaim (487_CR17) 2005; 2 SN Bhatia (487_CR5) 2014; 32 N Korin (487_CR32) 2012; 337 Z Li (487_CR35) 2016; 8 D Wlodkowic (487_CR60) 2010; 14 L Huang (487_CR26) 2015; 21 487_CR42 L Zhang (487_CR66) 2017; 7 H-F Tsai (487_CR55) 2017; 14 AI Astashkina (487_CR2) 2014; 35 T Mammoto (487_CR38) 2013; 29 EM Blais (487_CR6) 2017; 8 B Kwak (487_CR33) 2014; 194 DH Shin (487_CR51) 2017; 518 H Clevers (487_CR8) 2016; 165 D Schuster (487_CR48) 2005; 11 |
References_xml | – volume: 40 start-page: 233 year: 2011 end-page: 245 ident: CR7 article-title: Strategies for the intracellular delivery of nanoparticles publication-title: Chem Soc Rev contributor: fullname: Chan – volume: 17 start-page: 44 year: 2012 end-page: 55 ident: CR41 article-title: Toward in silico structure-based ADMET prediction in drug discovery publication-title: Drug Discov Today contributor: fullname: Miteva – volume: 30 start-page: 1355 year: 2017 end-page: 1364 ident: CR63 article-title: Evaluation of different methods for identification of structural alerts using chemical ames mutagenicity data set as a benchmark publication-title: Chem Res Toxicol contributor: fullname: Tang – volume: 29 start-page: 757 year: 2016 end-page: 767 ident: CR43 article-title: Computational models for human and animal hepatotoxicity with a global application scope publication-title: Em Res Toxicol contributor: fullname: Amberg – volume: 62 start-page: 4229 year: 2007 end-page: 4240 ident: CR11 article-title: Electroviscous effects in low Reynolds number liquid flow through a slit-like microfluidic contraction publication-title: Chem Eng Sci contributor: fullname: Harvie – volume: 13 start-page: 238 year: 1965 ident: CR3 article-title: Diffusion of univalent ions across the lamellae of swollen phospholipids publication-title: J Mol Biol contributor: fullname: Watkins – volume: 2 start-page: 875 year: 2006 end-page: 894 ident: CR40 article-title: Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction publication-title: Expert Opin Drug Metab Toxicol contributor: fullname: De Kanter – volume: 8 start-page: 14250 year: 2017 ident: CR6 article-title: Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions publication-title: Nat Commun contributor: fullname: Papin – volume: 10 start-page: 3991 year: 2019 ident: CR30 article-title: Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening publication-title: Nat Commun contributor: fullname: Jang – volume: 32 start-page: 760 year: 2014 end-page: 772 ident: CR5 article-title: Microfluidic organs-on-chips publication-title: Nat Biotechnol contributor: fullname: Ingber – volume: 54 start-page: 1061 year: 2014 end-page: 1069 ident: CR34 article-title: In silico prediction of chemical acute oral toxicity using multi-classification methods publication-title: J Chem Inf Model contributor: fullname: Tang – volume: 82 start-page: 808 year: 2010 end-page: 816 ident: CR64 article-title: Technique for real-time measurements of endothelial permeability in a microfluidic membrane chip using laser-induced fluorescence detection publication-title: Anal Chem contributor: fullname: Simmons – volume: 7 start-page: 211 year: 2006 end-page: 224 ident: CR21 article-title: Capturing complex 3D tissue physiology in vitro publication-title: Nat Rev Mol Cell Biol contributor: fullname: Swartz – ident: CR25 – volume: 50 start-page: 17 year: 2020 end-page: 27 ident: CR31 article-title: Solubility enhancement and application of cyclodextrins in local drug delivery publication-title: J Pharm Investig contributor: fullname: Park – volume: 5 start-page: 251 year: 2009 end-page: 273 ident: CR44 article-title: Translational nanomedicine: status assessment and opportunities publication-title: Nanomedicine contributor: fullname: Wright – volume: 21 start-page: 1364 year: 2015 end-page: 1371 ident: CR26 article-title: Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids publication-title: Nat Med contributor: fullname: Muthuswamy – volume: 51 start-page: 1 year: 2002 end-page: 16 ident: CR39 article-title: Chronic obstructive pulmonary disease surveillance—United States, 1971–2000 publication-title: Respir Care. contributor: fullname: Redd – ident: CR42 – volume: 8 start-page: 1022 year: 2016 end-page: 1029 ident: CR35 article-title: Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip publication-title: Int J Integr Biol contributor: fullname: Qin – volume: 7 start-page: 623 year: 2012 end-page: 629 ident: CR56 article-title: Microfluidic technologies for accelerating the clinical translation of nanoparticles publication-title: Nat Nanotechnol contributor: fullname: Langer – volume: 337 start-page: 738 year: 2012 end-page: 742 ident: CR32 article-title: Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels publication-title: Science contributor: fullname: Ingber – volume: 35 start-page: 6323 year: 2014 end-page: 6331 ident: CR2 article-title: Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model publication-title: Biomaterials contributor: fullname: Grainger – volume: 130 start-page: 601 year: 2007 end-page: 610 ident: CR62 article-title: Modeling tissue morphogenesis and cancer in 3D publication-title: Cell contributor: fullname: Cukierman – volume: 34 start-page: 97 year: 2016 end-page: 113 ident: CR19 article-title: New clues on carcinogenicity-related substructures derived from mining two large datasets of chemical compounds publication-title: J Environ Sciheal C contributor: fullname: Gini – volume: 4 start-page: 034111 year: 2010 ident: CR37 article-title: A new perspective on in vitro assessment method for evaluating quantum dot toxicity by using microfluidics technology publication-title: Biomicrofluidics contributor: fullname: Rhee – volume: 13 start-page: 653 year: 2013 end-page: 658 ident: CR49 article-title: Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients publication-title: Cell Stem Cell contributor: fullname: Clevers – volume: 165 start-page: 1586 year: 2016 end-page: 1597 ident: CR8 article-title: Modeling development and disease with organoids publication-title: Cell contributor: fullname: Clevers – volume: 106 start-page: 876 year: 2018 end-page: 886 ident: CR12 article-title: Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases publication-title: J Biomed Mater Res A contributor: fullname: Wang – volume: 4 start-page: 806 year: 2004 end-page: 813 ident: CR24 article-title: High interstitial fluid pressure—an obstacle in cancer therapy publication-title: Nat Rev Cancer contributor: fullname: Stman – volume: 22 start-page: 549 year: 2016 end-page: 565 ident: CR10 article-title: The three Rs of animal research: what they mean for the institutional animal care and use committee and why publication-title: Sci Eng Ethics contributor: fullname: Perry – volume: 376 start-page: 176 year: 2009 end-page: 185 ident: CR59 article-title: Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: Formulation, optimization and in vitro characterization publication-title: Int J Pharm contributor: fullname: Fang – volume: 14 start-page: 556 year: 2010 end-page: 567 ident: CR60 article-title: Tumors on chips: oncology meets microfluidics publication-title: Curr Opin Chem Biol contributor: fullname: Cooper – volume: 8 start-page: 201 year: 2012 end-page: 217 ident: CR46 article-title: In silico models for drug-induced liver injury—current status publication-title: Expert Opin Drug Metab Toxicol contributor: fullname: Cronin – volume: 5 start-page: 1089 year: 2005 end-page: 1095 ident: CR65 article-title: Diffusion dependent cell behavior in microenvironments publication-title: Lab Chip contributor: fullname: Beebe – volume: 9 start-page: 2026 year: 2009 end-page: 2035 ident: CR54 article-title: A microfluidic 3D hepatocyte chip for drug toxicity testing publication-title: Lab Chip contributor: fullname: Yu – volume: 172 start-page: 38 year: 2013 end-page: 47 ident: CR1 article-title: The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage publication-title: J Control Release contributor: fullname: Ishida – volume: 159 start-page: 176 year: 2014 end-page: 187 ident: CR18 article-title: Organoid cultures derived from patients with advanced prostate cancer publication-title: Cell contributor: fullname: Chen – volume: 73 start-page: 1240 year: 2001 end-page: 1246 ident: CR13 article-title: Generation of gradients having complex shapes using microfluidic networks publication-title: Anal Chem contributor: fullname: Whitesides – volume: 194 start-page: 157 year: 2014 end-page: 167 ident: CR33 article-title: Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip publication-title: J Control Release contributor: fullname: Han – volume: 9 start-page: 647 year: 2014 end-page: 656 ident: CR50 article-title: Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening publication-title: Int J Chron Obstruct Pulmon Dis contributor: fullname: Fujisawa – volume: 14 start-page: 20170137 year: 2017 ident: CR55 article-title: Tumour-on-a-chip: Microfluidic models of tumour morphology, growth and microenvironment publication-title: J R Soc Interface contributor: fullname: Bao – volume: 7 start-page: 2118 year: 2017 ident: CR66 article-title: CarcinoPred-EL: Novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods publication-title: Sci Rep contributor: fullname: Liu – volume: 58 start-page: 1456 year: 2006 end-page: 1459 ident: CR16 article-title: Nanomedicine: Developing smarter therapeutic and diagnostic modalities publication-title: Adv Drug Deliv Rev contributor: fullname: Langer – volume: 141 start-page: 1762 year: 2011 end-page: 1772 ident: CR47 article-title: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium publication-title: Gastroenterology contributor: fullname: Clevers – volume: 10 start-page: 4940 year: 2018 end-page: 4951 ident: CR23 article-title: In-silico design of nanoparticles for transdermal drug delivery application publication-title: Nanoscale contributor: fullname: Rai – volume: 11 start-page: 3545 year: 2005 end-page: 3559 ident: CR48 article-title: Why drugs fail—a study on side effects in new chemical entities publication-title: Curr Pharm Des contributor: fullname: Langer – volume: 35 start-page: 564 year: 2003 end-page: 577 ident: CR27 article-title: Mechanobiology and diseases of mechanotransduction publication-title: Ann Med contributor: fullname: Ingber – volume: 29 start-page: 27 year: 2013 end-page: 61 ident: CR38 article-title: Mechanobiology and developmental control publication-title: Annu Rev Cell Dev Biol contributor: fullname: Ingber – volume: 518 start-page: 307 year: 2017 end-page: 311 ident: CR51 article-title: Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy publication-title: Int J Pharm contributor: fullname: Kwon – volume: 19 start-page: 1326 year: 2017 end-page: 1335 ident: CR9 article-title: Synthetic hydrogels for human intestinal organoid generation and colonic wound repair publication-title: Nat Cell Biol contributor: fullname: Garcia – volume: 10 start-page: 201 year: 2019 ident: CR20 article-title: Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases publication-title: Cell Death Dis contributor: fullname: Bonci – volume: 8 start-page: 415 year: 2011 end-page: 433 ident: CR4 article-title: Cell-mediated drug delivery publication-title: Expert Opin Drug Deliv contributor: fullname: Kabanov – volume: 52 start-page: S4 year: 2017 end-page: S14 ident: CR22 article-title: Toward inclusive therapy with CFTR modulators: progress and challenges publication-title: Pediatric Pulm contributor: fullname: Rowe – volume: 57 start-page: 2672 year: 2017 end-page: 2685 ident: CR61 article-title: Deep learning based regression and multiclass models for acute oral toxicity prediction with automatic chemical feature extraction publication-title: J Chem Inf Model contributor: fullname: Lai – volume: 14 start-page: 248 year: 2015 end-page: 260 ident: CR15 article-title: Organs-on-chips at the frontiers of drug discovery publication-title: Nat Rev Drug Discov contributor: fullname: Huh – volume: 2 start-page: 192 year: 2003 end-page: 204 ident: CR57 article-title: ADMET in silico modelling: towards prediction paradise? publication-title: Nat Rev Drug Discov contributor: fullname: Gifford – volume: 2 start-page: 119 year: 2005 end-page: 125 ident: CR17 article-title: An extracellular matrix microarray for probing cellular differentiation publication-title: Nat Med contributor: fullname: Bhatia – volume: 8 start-page: 34 year: 2008 end-page: 57 ident: CR28 article-title: Biomolecular gradients in cell culture systems publication-title: Lab Chip contributor: fullname: Folch – volume: 74 start-page: 5184 year: 2014 end-page: 5194 ident: CR58 article-title: Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer publication-title: Cancer Res contributor: fullname: Skala – volume: 89 start-page: 114103 year: 2006 ident: CR29 article-title: Microfluidic “jets” for generating steady-state gradients of soluble molecules on open surfaces publication-title: Appl Phys Lett contributor: fullname: Folch – volume: 21 start-page: 219 year: 2019 end-page: 239 ident: CR14 article-title: Challenges and opportunities in the design of liver-on-chip microdevices publication-title: Annu Rev Biomed Eng contributor: fullname: Nahmias – volume: 107 start-page: 3141 year: 2010 end-page: 3145 ident: CR45 article-title: Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures publication-title: Proc Natl Acad Sci contributor: fullname: Bhatia – volume: 9 start-page: 1385 year: 2009 end-page: 1394 ident: CR53 article-title: A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs publication-title: Lab Chip contributor: fullname: Shuler – volume: 123 start-page: 3801 year: 2019 end-page: 3810 ident: CR36 article-title: In silico study of gold nanoparticle uptake into a mammalian cell: interplay of size, shape, surface charge, and aggregation publication-title: J Phys Chem C contributor: fullname: Puangmali – volume: 77 start-page: 977 year: 2005 end-page: 1026 ident: CR52 article-title: Microfluidics: Fluid physics at the nanoliter scale publication-title: Rev Mod Phys contributor: fullname: Quake – volume: 2 start-page: 875 year: 2006 ident: 487_CR40 publication-title: Expert Opin Drug Metab Toxicol doi: 10.1517/17425255.2.6.875 contributor: fullname: M Martignoni – volume: 35 start-page: 564 year: 2003 ident: 487_CR27 publication-title: Ann Med doi: 10.1080/07853890310016333 contributor: fullname: D Ingber – volume: 50 start-page: 17 year: 2020 ident: 487_CR31 publication-title: J Pharm Investig doi: 10.1007/s40005-019-00434-2 contributor: fullname: D-H Kim – volume: 123 start-page: 3801 year: 2019 ident: 487_CR36 publication-title: J Phys Chem C doi: 10.1021/acs.jpcc.8b07616 contributor: fullname: T Lunnoo – volume: 73 start-page: 1240 year: 2001 ident: 487_CR13 publication-title: Anal Chem doi: 10.1021/ac001132d contributor: fullname: SKW Dertinger – volume: 58 start-page: 1456 year: 2006 ident: 487_CR16 publication-title: Adv Drug Deliv Rev doi: 10.1016/j.addr.2006.09.011 contributor: fullname: OC Farokhzad – volume: 52 start-page: S4 year: 2017 ident: 487_CR22 publication-title: Pediatric Pulm doi: 10.1002/ppul.23773 contributor: fullname: J Guimbellot – volume: 9 start-page: 647 year: 2014 ident: 487_CR50 publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S62053 contributor: fullname: Y Sekine – volume: 376 start-page: 176 year: 2009 ident: 487_CR59 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2009.04.030 contributor: fullname: Z Wei – volume: 159 start-page: 176 year: 2014 ident: 487_CR18 publication-title: Cell doi: 10.1016/j.cell.2014.08.016 contributor: fullname: D Gao – volume: 518 start-page: 307 year: 2017 ident: 487_CR51 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2017.01.006 contributor: fullname: DH Shin – volume: 10 start-page: 4940 year: 2018 ident: 487_CR23 publication-title: Nanoscale doi: 10.1039/C7NR07898F contributor: fullname: R Gupta – volume: 194 start-page: 157 year: 2014 ident: 487_CR33 publication-title: J Control Release doi: 10.1016/j.jconrel.2014.08.027 contributor: fullname: B Kwak – volume: 8 start-page: 201 year: 2012 ident: 487_CR46 publication-title: Expert Opin Drug Metab Toxicol doi: 10.1517/17425255.2012.648613 contributor: fullname: KR Przybylak – volume: 89 start-page: 114103 year: 2006 ident: 487_CR29 publication-title: Appl Phys Lett doi: 10.1063/1.2345914 contributor: fullname: TM Keenan – volume: 5 start-page: 1089 year: 2005 ident: 487_CR65 publication-title: Lab Chip doi: 10.1039/b504403k contributor: fullname: H Yu – volume: 2 start-page: 119 year: 2005 ident: 487_CR17 publication-title: Nat Med contributor: fullname: CJ Flaim – volume: 17 start-page: 44 year: 2012 ident: 487_CR41 publication-title: Drug Discov Today doi: 10.1016/j.drudis.2011.10.023 contributor: fullname: G Moroy – volume: 11 start-page: 3545 year: 2005 ident: 487_CR48 publication-title: Curr Pharm Des doi: 10.2174/138161205774414510 contributor: fullname: D Schuster – volume: 130 start-page: 601 year: 2007 ident: 487_CR62 publication-title: Cell doi: 10.1016/j.cell.2007.08.006 contributor: fullname: KM Yamada – volume: 7 start-page: 2118 year: 2017 ident: 487_CR66 publication-title: Sci Rep doi: 10.1038/s41598-017-02365-0 contributor: fullname: L Zhang – volume: 34 start-page: 97 year: 2016 ident: 487_CR19 publication-title: J Environ Sciheal C doi: 10.1080/10590501.2016.1166879 contributor: fullname: A Golbamaki – volume: 5 start-page: 251 year: 2009 ident: 487_CR44 publication-title: Nanomedicine doi: 10.1016/j.nano.2009.06.001 contributor: fullname: J Murday – volume: 62 start-page: 4229 year: 2007 ident: 487_CR11 publication-title: Chem Eng Sci doi: 10.1016/j.ces.2007.05.006 contributor: fullname: MR Davidson – volume: 4 start-page: 034111 year: 2010 ident: 487_CR37 publication-title: Biomicrofluidics doi: 10.1063/1.3486610 contributor: fullname: SK Mahto – volume: 14 start-page: 248 year: 2015 ident: 487_CR15 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd4539 contributor: fullname: EW Esch – volume: 8 start-page: 14250 year: 2017 ident: 487_CR6 publication-title: Nat Commun doi: 10.1038/ncomms14250 contributor: fullname: EM Blais – volume: 13 start-page: 653 year: 2013 ident: 487_CR49 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2013.11.002 contributor: fullname: G Schwank – volume: 14 start-page: 556 year: 2010 ident: 487_CR60 publication-title: Curr Opin Chem Biol doi: 10.1016/j.cbpa.2010.08.016 contributor: fullname: D Wlodkowic – volume: 54 start-page: 1061 year: 2014 ident: 487_CR34 publication-title: J Chem Inf Model doi: 10.1021/ci5000467 contributor: fullname: X Li – volume: 141 start-page: 1762 year: 2011 ident: 487_CR47 publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.07.050 contributor: fullname: T Sato – volume: 9 start-page: 1385 year: 2009 ident: 487_CR53 publication-title: Lab Chip doi: 10.1039/b901377f contributor: fullname: JH Sung – volume: 51 start-page: 1 year: 2002 ident: 487_CR39 publication-title: Respir Care. contributor: fullname: DM Mannino – volume: 22 start-page: 549 year: 2016 ident: 487_CR10 publication-title: Sci Eng Ethics doi: 10.1007/s11948-015-9659-8 contributor: fullname: HJ Curzer – volume: 7 start-page: 623 year: 2012 ident: 487_CR56 publication-title: Nat Nanotechnol doi: 10.1038/nnano.2012.168 contributor: fullname: PM Valencia – volume: 77 start-page: 977 year: 2005 ident: 487_CR52 publication-title: Rev Mod Phys doi: 10.1103/RevModPhys.77.977 contributor: fullname: TM Squires – volume: 8 start-page: 34 year: 2008 ident: 487_CR28 publication-title: Lab Chip doi: 10.1039/B711887B contributor: fullname: TM Keenan – volume: 106 start-page: 876 year: 2018 ident: 487_CR12 publication-title: J Biomed Mater Res A doi: 10.1002/jbm.a.36305 contributor: fullname: Z Davoudi – volume: 19 start-page: 1326 year: 2017 ident: 487_CR9 publication-title: Nat Cell Biol doi: 10.1038/ncb3632 contributor: fullname: R Cruz-Acuna – volume: 337 start-page: 738 year: 2012 ident: 487_CR32 publication-title: Science doi: 10.1126/science.1217815 contributor: fullname: N Korin – volume: 107 start-page: 3141 year: 2010 ident: 487_CR45 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.0915130107 contributor: fullname: A Ploss – volume: 29 start-page: 757 year: 2016 ident: 487_CR43 publication-title: Em Res Toxicol doi: 10.1021/acs.chemrestox.5b00465 contributor: fullname: D Mulliner – volume: 8 start-page: 415 year: 2011 ident: 487_CR4 publication-title: Expert Opin Drug Deliv doi: 10.1517/17425247.2011.559457 contributor: fullname: EV Batrakova – volume: 32 start-page: 760 year: 2014 ident: 487_CR5 publication-title: Nat Biotechnol doi: 10.1038/nbt.2989 contributor: fullname: SN Bhatia – volume: 40 start-page: 233 year: 2011 ident: 487_CR7 publication-title: Chem Soc Rev doi: 10.1039/C0CS00003E contributor: fullname: LYT Chou – volume: 30 start-page: 1355 year: 2017 ident: 487_CR63 publication-title: Chem Res Toxicol doi: 10.1021/acs.chemrestox.7b00083 contributor: fullname: H Yang – volume: 74 start-page: 5184 year: 2014 ident: 487_CR58 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-14-0663 contributor: fullname: AJ Walsh – volume: 13 start-page: 238 year: 1965 ident: 487_CR3 publication-title: J Mol Biol doi: 10.1016/S0022-2836(65)80093-6 contributor: fullname: AD Bangham – volume: 35 start-page: 6323 year: 2014 ident: 487_CR2 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.04.060 contributor: fullname: AI Astashkina – ident: 487_CR42 – volume: 7 start-page: 211 year: 2006 ident: 487_CR21 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm1858 contributor: fullname: LG Griffith – volume: 165 start-page: 1586 year: 2016 ident: 487_CR8 publication-title: Cell doi: 10.1016/j.cell.2016.05.082 contributor: fullname: H Clevers – volume: 2 start-page: 192 year: 2003 ident: 487_CR57 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1032 contributor: fullname: H Van De Waterbeemd – volume: 10 start-page: 201 year: 2019 ident: 487_CR20 publication-title: Cell Death Dis doi: 10.1038/s41419-019-1453-0 contributor: fullname: L Grassi – volume: 172 start-page: 38 year: 2013 ident: 487_CR1 publication-title: J Control Release doi: 10.1016/j.jconrel.2013.07.026 contributor: fullname: AS Abu Lila – volume: 21 start-page: 1364 year: 2015 ident: 487_CR26 publication-title: Nat Med doi: 10.1038/nm.3973 contributor: fullname: L Huang – volume: 29 start-page: 27 year: 2013 ident: 487_CR38 publication-title: Annu Rev Cell Dev Biol doi: 10.1146/annurev-cellbio-101512-122340 contributor: fullname: T Mammoto – volume: 14 start-page: 20170137 year: 2017 ident: 487_CR55 publication-title: J R Soc Interface doi: 10.1098/rsif.2017.0137 contributor: fullname: H-F Tsai – ident: 487_CR25 – volume: 8 start-page: 1022 year: 2016 ident: 487_CR35 publication-title: Int J Integr Biol doi: 10.1039/C6IB00162A contributor: fullname: Z Li – volume: 82 start-page: 808 year: 2010 ident: 487_CR64 publication-title: Anal Chem doi: 10.1021/ac901560w contributor: fullname: EWK Young – volume: 9 start-page: 2026 year: 2009 ident: 487_CR54 publication-title: Lab Chip doi: 10.1039/b900912d contributor: fullname: Y-C Toh – volume: 21 start-page: 219 year: 2019 ident: 487_CR14 publication-title: Annu Rev Biomed Eng doi: 10.1146/annurev-bioeng-060418-052305 contributor: fullname: A Ehrlich – volume: 10 start-page: 3991 year: 2019 ident: 487_CR30 publication-title: Nat Commun doi: 10.1038/s41467-019-11867-6 contributor: fullname: M Kim – volume: 57 start-page: 2672 year: 2017 ident: 487_CR61 publication-title: J Chem Inf Model doi: 10.1021/acs.jcim.7b00244 contributor: fullname: Y Xu – volume: 4 start-page: 806 year: 2004 ident: 487_CR24 publication-title: Nat Rev Cancer doi: 10.1038/nrc1456 contributor: fullname: C-H Heldin |
SSID | ssj0000561889 |
Score | 2.2397077 |
SecondaryResourceType | review_article |
Snippet | Background
Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans.... Background Animals have been used for the testing of new drugs and nanoparticles to determine their safety and effectiveness before application in humans.... |
SourceID | nrf crossref springer |
SourceType | Open Website Aggregation Database Publisher |
StartPage | 327 |
SubjectTerms | Biomedical and Life Sciences Biomedicine Review 약학 |
Title | Replacement techniques to reduce animal experiments in drug and nanoparticle development |
URI | https://link.springer.com/article/10.1007/s40005-020-00487-8 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002587441 |
Volume | 50 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Pharmaceutical Investigation, 2020, 50(3), , pp.327-335 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LSwMxEA62vXjxgYr1UYJ40y3bJLvdHItYq6KnFuopZDdJKcVUttuLv97JPrpIRegph2wGdmaSfJPMfEHoFowcGhmA82o_8lgMUzGCFdJjXDGlfWP6eW3V23s4mrCXaTCt67jzZPfqRjJfqDe1bszBC89FO87rQGQDtcrC09bg6eO1PlpxoDjKH78jEK97QRCQslzmb0G_tqSGTc3WrWi-2QwP0bgq2SlyTBbddRZ3k-9tBsdd_uMIHZTgEw8KbzlGe9qeoClgcHeW7o4J8YbSdYWzJU4dr6vG0s4_YVj9GMAKzy1W6XoGXQpbaSHyLmRiVSchnaLJ8HH8MPLK9xa8hJIg8yhJVAJwLJaahopG0DAeKq6JpISqRHGAc5pCt6EhxFkm8HsJQD5pOIl7MaVnqGmXVp8j7IeSq56UIeE91mcyMoQbLqM4lkGilWyju0rl4qug1RAbAuVcQwI0JHINiaiNbsAqYpHMhWPDdu1sKRapAMz_LADgOZ65NrqvFC7Kebj6R-bFbp9fon2S28ylOl6hZpau9TXAkSzulO7XQY0JGfwAq4PV7w |
link.rule.ids | 315,783,787,27936,27937,41093,41535,42162,42604,52123,52246 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3PS8MwFA5uHvQiiorzZxBvWuiStGuOQxybbjttsFtIm2SMYSZt9__7krUVUQRPOaR9h_deku-9vPcFoQcwcmxkBM6rwyRgKSzFBHbIgHHFlA6N6fneqsk0Hs7Z6yJaVE1hRV3tXl9J-p26aXZjDl8ELtxxbgcyW2jf8as7xvw56TeZFYeJE__2HYFwPYiiiFTdMr-L-XYitWxuflyK-rNmcIyOKpCI-zurnqA9bU_RArCyy3m7dB5uqFcLXG5w7vhXNZZ29Q6_fZH2F3hlscq3S5hS2EoLEfJOJlZfxUJnaD54mT0Pg-pdhCCjJCoDSjKVAWxKpaaxogkMjMeKayIpoSpTHGCXpjBtaAzxkInCbgbQTBpO0m5K6Tlq243VFwiHseSqK2VMeJf1mEwM4YbLJE1llGklO-ix1o342NFfiIbo2GtSgCaF16RIOuge1CfW2Uo41mo3LjdinQvA5iMBQMzxwXXQU61dUa2X4g-Zl__7_A4dDGeTsRiPpm9X6JB4O7vyxGvULvOtvgEIUaa33mM-AY_Bu-w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA9ugvgiiorzM4hvWtYmTdc8DnVsfgwfHOwtpE0yxjAbXff_e2m7TlEEn_KQ5h4ul97vLne_IHQDmxwZycB4tR97YQJHMYY_pBdyFSrtG9Mpeqteh1F_FD6N2fhLF39R7b6-kix7GhxLk83bC2XadeNb6LCG50IfZ4Igv4G2wRVRV9Q3It06y-LwcVy8g0cgdPcYY6TqnPldzDfv1LCZ-XFBWvid3j7aqwAj7pY7fIC2tD1EY8DNLv_tUnu4pmFd4nyOM8fFqrG00w9YtiHwX-KpxSpbTWBKYSstRMulTKw2hUNHaNR7fL_ve9UbCV5KCcs9SlKVAoRKpKaRojEMIY8U10RSQlWqOEAwTWHa0AhiI8P8IAWYJg0nSZBQeoyadm71CcJ-JLkKpIwID8JOKGNDuOEyThLJUq1kC92udSMWJRWGqEmPC00K0KQoNCniFroG9YlZOhWOwdqNk7mYZQJw-kAAKHPccC10t9auqM7O8g-Zp__7_ArtvD30xMtg-HyGdkmxza5S8Rw182ylLwBN5MllYTCf08PAMQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Replacement+techniques+to+reduce+animal+experiments+in+drug+and+nanoparticle+development&rft.jtitle=Journal+of+pharmaceutical+investigation&rft.au=Jin%2C+Ik+Sup&rft.au=Yoon%2C+Moon+Sup&rft.au=Park%2C+Chun-Woong&rft.au=Hong%2C+Jin+Tae&rft.date=2020-05-01&rft.issn=2093-5552&rft.eissn=2093-6214&rft.volume=50&rft.issue=3&rft.spage=327&rft.epage=335&rft_id=info:doi/10.1007%2Fs40005-020-00487-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s40005_020_00487_8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-5552&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-5552&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-5552&client=summon |